Additional Study Information: The purpose of this research study is to see if an investigational drug, BB3, is safe and effective forincreasing the amount of urine that a transplanted kidney will produce. An investigational drugis one that is not approved by the United States Food and Drug Administration (FDA). BB3 is agrowth factor-like drug, which means that it can affect cell function and growth. It is possible thatBB3 can help injured organs to improve their function if it is given shortly after the injury occurssuch as a transplant. BB3 is given intravenously (IV) through a vein.